Literature DB >> 20524961

Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair.

Gabrièle Piaton1, Robert M Gould, Catherine Lubetzki.   

Abstract

In multiple sclerosis, CNS demyelination is often followed by spontaneous repair, mostly achieved by adult oligodendrocyte precursor cells. Extent of this myelin repair differs, ranging from very low, limited to the plaque border, to extensive, with remyelination throughout the 'shadow plaques.' In addition to restoring neuronal connectivity, new myelin is neuroprotective. It reduces axonal loss and thus disability progression. Reciprocal communication between neurons and oligodendrocytes is essential for both myelin biogenesis and myelin repair. Hence, deciphering neuron-oligodendrocyte communication is not only important for understanding myelination per se, but also the pathophysiology that underlies demyelinating diseases and the development of innovative therapeutic strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20524961     DOI: 10.1111/j.1471-4159.2010.06831.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

2.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

Review 3.  Oligodendrocytes: Myelination and Axonal Support.

Authors:  Mikael Simons; Klaus-Armin Nave
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-22       Impact factor: 10.005

4.  Sirt2 epigenetically down-regulates PDGFRα expression and promotes CG4 cell differentiation.

Authors:  Na Fang; Junjun Cheng; Chu Zhang; Keyuan Chen; Chenyu Zhang; Zichao Hu; Ran Bi; Kendra L Furber; Merlin Thangaraj; Adil J Nazarali; Shaoping Ji
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

5.  PIKE is essential for oligodendroglia development and CNS myelination.

Authors:  Chi Bun Chan; Xia Liu; Lixia Zhao; Guanglu Liu; Chi Wai Lee; Yue Feng; Keiqang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

6.  JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons.

Authors:  Nana Merabova; Rafal Kaminski; Barbara Krynska; Shohreh Amini; Kamel Khalili; Armine Darbinyan
Journal:  J Cell Physiol       Date:  2012-08       Impact factor: 6.384

Review 7.  p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.

Authors:  Paschalis Theotokis; Nikolaos Grigoriadis
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

8.  Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy.

Authors:  Samuel Groeschel; Christine í Dali; Philipp Clas; Judith Böhringer; Morten Duno; Christian Krarup; Christiane Kehrer; Marko Wilke; Ingeborg Krägeloh-Mann
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

9.  Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion.

Authors:  Akihiro Ishii; Miki Furusho; Rashmi Bansal
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

10.  Neonatal hyperoxia exposure disrupts axon-oligodendrocyte integrity in the subcortical white matter.

Authors:  Jonathan Ritter; Thomas Schmitz; Li-Jin Chew; Christoph Bührer; Wiebke Möbius; Marzieh Zonouzi; Vittorio Gallo
Journal:  J Neurosci       Date:  2013-05-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.